Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3
- Central Nervous System
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 215874
IPSCIO Record ID: 344504
Licensor grants an exclusive license to use the Licensor Trademarks in connection with any Licensed Products that Licensee uses, markets, promotes, distributes, imports, commercializes, offers for sale or sells within the Field and Territory either directly on its own and/or through its Affiliates, sublicensee, and/or distributors.
Licensor grants a non-exclusive license to use the Licensor Logo on all packaging materials, promotional materials and documents that are used by Licensee either directly on its own and/or through its sublicensee, contractors or distributors in connection with the development, promotion, marketing, offer for sale, sale, import and commercialization of the Licensed Products.
Licensor grants a worldwide, non-exclusive license, without any right to sub-license, under the Licensor Patents and Licensor Know-How to develop or have developed on its behalf, Licensed Products for use and sale within the Field and the Territory,
Licensed Products means the xxx 2-093 Product and all other products, including any current or future dosages, formulations, improvements and/or delivery modes comprising xxx 2-093 and all possible metabolites, salts, hydrates, polymorphs, crystalline forms, solvates and prodrugs thereof, including any present and future combination products containing xxx 2-093 or a metabolite, salt, hydrate, polymorph, crystalline form, solvate or prodrug thereof, as one of the active ingredients.
xxx 2-093 means Licensors proprietary compound (S)-(-)-10-acetoxy-10,11- dihydro-SH-dibenz/b,f/azepine-5-carboxamide, known under the International Nonproprietary Name (INN) Eslicarbazepine Acetate.
Licensor Trademarks mean ERELIB' and PAZZUL.
The logo is BIAL.
SEP-0002093 is a new chemical entity which is intended to offer patients suffering with partial epilepsy additional control of their seizures and improved quality of life. Licensor has completed a Phase III program in Europe for the adjunctive treatment of epilepsy.
The Field means all human and non-human diagnostic, prophylactic and therapeutic uses of the Licensed Products for adjunctive use in Adult Partial Epileptic Seizures and any and all new indications, including but not limited to Epilepsy Monotherapy, Trigeminal Neuralgia, Diabetic Neuropathic Pain and Post-herpetic Neuralgia.
IPSCIO Record ID: 343475